
ImmunityBio, Inc.
IBRXNasdaqCIK 1326110HealthcareFiscal year ends Dec 31
Reports and events: 180 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-06-1117:18 ET | 8-K | 2.02 Results of operations; 5.07 Shareholder vote results | 0001193125-21-189023 |
| 2021-06-0408:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-182190 |
| 2021-05-2816:08 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-21-176935 |
| 2021-05-1416:06 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001564590-21-028010 |
| 2021-05-0306:06 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-146472 |
| 2021-04-2916:31 ET | DEF 14A | Proxy statementPeriod 2021-06-10 | 0001193125-21-140564 |
| 2021-04-2216:06 ET | 8-K/A | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-126681 |
| 2021-04-0109:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-103380 |
| 2021-03-1717:24 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-084244 |
| 2021-03-1214:59 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-21-079404 |
| 2021-03-1021:58 ET | 8-K | 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-075243 |
| 2021-03-0416:11 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001564590-21-010945 |
| 2021-02-2517:15 ET | 8-K | 8.01 Other events | 0001193125-21-057184 |
| 2021-02-2416:59 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-054808 |
| 2021-02-1016:38 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-21-036358 |
| 2021-01-1309:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-007807 |
| 2020-12-2206:07 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-20-323766 |
| 2020-12-2110:58 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-20-322658 |
| 2020-12-2107:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-322298 |
| 2020-11-0916:06 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001564590-20-052488 |
| 2020-10-2617:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-20-277062 |
| 2020-08-2416:10 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-20-228341 |
| 2020-08-0709:01 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001564590-20-038096 |
| 2020-06-2919:09 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-20-182706 |
| 2020-06-2516:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-179095 |
| 2020-06-2417:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-177788 |
| 2020-06-1916:33 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-20-174073 |
| 2020-06-1218:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-20-166829 |
| 2020-05-2716:10 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-20-153068 |
| 2020-05-1116:06 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001564590-20-024168 |
| 2020-04-2416:02 ET | DEF 14A | Proxy statementPeriod 2020-06-10 | 0001193125-20-119033 |
| 2020-03-2516:09 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001564590-20-012816 |
| 2019-11-0516:06 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001564590-19-040363 |
| 2019-08-0716:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-19-215311 |
| 2019-08-0616:07 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001564590-19-029330 |
| 2019-06-1016:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-19-169172 |
| 2019-06-0716:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-19-168170 |
| 2019-05-0816:06 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001564590-19-017179 |
| 2019-04-2616:06 ET | DEF 14A | Proxy statementPeriod 2019-06-06 | 0001193125-19-122311 |
| 2019-04-0116:06 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-19-094504 |
| 2019-03-1316:07 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001564590-19-007562 |
| 2018-11-0716:08 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001564590-18-028007 |
| 2018-08-0616:06 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001564590-18-019420 |
| 2018-06-1316:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-18-191630 |
| 2018-05-0716:06 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001564590-18-011240 |
| 2018-04-2416:05 ET | DEF 14A | Proxy statementPeriod 2018-06-07 | 0001193125-18-128761 |
| 2018-04-1716:45 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-18-119869 |
| 2018-03-1216:07 ET | 10-K | Annual reportPeriod 2017-12-31 | 0001564590-18-005290 |
| 2017-11-0716:04 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001564590-17-022217 |
| 2017-09-2216:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-17-291376 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 9, 2026, 17:45 ET. Listed shows no prices and gives no investment advice.